Deletions aecting the interval between the RB1 gene and marker D13S25 at band 13q14 are the most frequent genetic abnormalities of B-cell chronic lymphocytic leukemia (B-CLL) and indicate the presence of a novel tumor suppressor gene in this region. In the current study, a high resolution physical map of fragments spanning one megabasepair (Mb) of genomic DNA at the critical 13q14 segment was constructed. To de®ne the minimal region of loss within the RB1 and D13S25 interval, we screened 322 B-CLLs for deletions at either of the two loci. Thirty mantle cell lymphomas (MCLs) were included in the analysis because we observed a 13q14 deletion pattern similar to B-CLL in this disease. The incidence of 13q14 deletions was 51% in B-CLL and 70% in MCL, respectively. No frequent loss of the BRCA2 gene at band 13q12 was found. Detailed deletion mapping at band 13q14 with probes from the RB1 ± D13S25 interval lead to the identi®cation of a critical deletion region 400 kb in size. Within this region two segments were most frequently aected, one at D13S272 120 kb in size and another 240 kb distal of D13S272 80 kb in size. From these two segments expressed sequences were identi®ed as candidates for the putative 13q14 tumor suppressor gene involved in the pathogenesis of B-CLL and MCL.
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Keywords: deletion mapping; FISH; exon ampli®cation; DIRVISH The molecular pathogenesis of B-CLL, the most frequent leukemia in Western countries, is not well understood (Rozman and Montserrat, 1995) . Although a number of recurrent chromosome aberrations have been identi®ed, no gene to date has been found to be consistently involved (Juliusson et al., 1990; DoÈ hner et al., 1997a) .
The most common structural chromosome aberrations in B-CLL involve band 13q14 (Juliusson et al., 1990) , to which the RB1 tumor suppressor gene has been localized (Friend et al., 1986) . Monoallelic RB1 deletion was frequently observed in B-CLL but disruption of both RB1 alleles occurred rarely (Liu et al., 1992 (Liu et al., , 1993 Stilgenbauer et al., 1993) . Based on the observation that the distal marker D13S25 was deleted more frequently than RB1, a novel B-CLL tumor suppressor gene located in vicinity to this marker was postulated (Brown et al., 1993; Liu et al., 1993; Chapman et al., 1994) .
Subsequent studies aimed at the localization of this gene have been thus far inconclusive. Devilder et al. (1995) localized a minimal deletion segment distal of D13S25. However, comparing deletions of RB1 and D13S25 lead us to the hypothesis that the critical segment is localized proximal of D13S25 (Stilgenbauer et al., 1995) . This was supported by Liu et al. (1995) who found loss of D13S319 located less than 680 kb proximal of D13S25 more frequently deleted than other 13q14 markers. Bullrich et al. (1996) recently assembled a YAC contig to order new markers in the region and identi®ed a minimal deletion between D13S25 and the marker 206XF12 located less than 550 kb proximal of D13S25. However, in this study deletions did not appear to cluster in a single critical region and the potential signi®cance of several dierent loci was raised. In a recent study Garcia-Marco et al. (1996) reported another deletion region aecting the BRCA2 locus at band 13q12 independent of deletions of RB1 and D13S25 at 13q14.
To provide a basis for the identi®cation of a potential B-CLL tumor suppressor gene at 13q14, we here report the construction of a high resolution physical map of DNA fragments (contig) spanning the critical region. Fragments from this contig as well as from the BRCA2 and RB1 loci were used to assess a minimal deletion segment and to identify transcribed sequences derived from this region.
Construction of a contig spanning the critical 13q14 region
Oligonucleotides for markers D13S118, D13S165, D13S273, D13S272 were used to identify cosmids from high density ®lter grids. Chromosomal localization and marker content of the isolated cosmids were con®rmed by FISH and Southern blot analysis, respectively. Positive cosmids were subsequently used as probes to identify larger fragments cloned in PACs. By this approach cosmids c- 118-11, c-165-24, c-273-19, c-272-3 and c-25-1/2 as well as PAC-273-2, PAC-272-3, PAC-272-1-1 and PAC-H2-42 were selected as anchor points for contig construction (Figure 1a) . To obtain a set of PACs covering the critical region, probes derived from YAC 933e9, (containing D13S273, D13S272 and D13S25; CEPH-GeÂ neÂ thon and own data) and YAC 804d9, containing D13S272 (data not shown) were used. Identi®ed PACs were chromosomally mapped by FISH, sized by PFGE of NotI digests and ®ngerprinted by HindIII digestion. Overlaps were identi®ed by Southern blot analyses. To form a contig individual clones were used as probes back to PAC library ®lters. At positions where gaps in the PAC library were evident, BACs (BAC-10-9, BAC-11-5) and a cosmid (c-58-2-3) isolated from the respective libraries were integrated into the contig (see Figure 1 ).
Molecular cytogenetic characterization of the 13q14 contig
High resolution mapping was performed on elongated DNA ®bers to con®rm the order of fragments forming the 13q14 contig and to exclude deletions or chimerism a b c Figure 1 Physical contig spanning 1 Mb of genomic DNA at the D13S273 ± D13S25 interval. (a) The genetic map in centromere (left) to telomere (right) orientation and a selection of PACs, BACs and cosmids are illustrated. Overlaps and distances were measured by DIRVISH (Parra and Windle, 1993) . Cosmids and PACs were identi®ed from high density ®lters obtained from the Resource Center/Reference Library of the German Human Genome Project (Lehrach et al., 1990) . BACs were isolated from a human BAC library (Research Genetics, Huntsville, AL). Oligonucleotides for the respective markers (CEPH-GeÂ neÂ thon, http:// www.cephb.fr/ceph-genethon-map.html) and inter-Alu-PCR (Lengauer et al., 1992) or sequence independent ampli®cation (SIA) PCR (Bohlander et al., 1992) products of YACs 933e9 and 804d9 (CEPH-GeÂ neÂ thon) were used as probes. Oligonucleotides were end-labeled while all other probes were labeled by the random primed method and hybridized in the presence of a 1000-fold excess of C 0 t-1 DNA. (b) Re®ned contig of the PAC-272-3 region. Exon ampli®cation was performed from PAC-272-3 using the lGET vector (Nehls et al., 1994) . Sequence analysis of cloned products (pT-Adv PCR cloning vector; Clontech, Palo Alto, CA) was performed on an ABI377 sequencer (Perkin-Elmer, Weiterstadt, Germany). Six exons with matches in the EST database are contained in four dierent transcripts (PCR 9-57, ep272-3 t4, ep272-3 t5, ep272-3 t10). cDNAs were isolated by screening high density ®lter grids (libraries fetal brain, no. 507; fetal liver, no. 512; and fetal thymus, no. 508; Resource Center/Reference Library of the German Human Genome Project; Lehrach et al., 1990) with the exon ampli®cation products. Details of the cDNAs containing the exons are given in Table 2 . (c) Re®ned contig of the the PAC-58 region. The 4 exons (exons 4, 7, 21, 36) identi®ed from PAC-58 are shown. None of these exons had matches to known ESTs within inserts (Figure 2a ). Simultaneous hybridization of three to four adjacent probes allowed us to delineate stepwise the entire contig thereby con®rming its integrity. The length of the hybridization signals was measured and, together with sizing data obtained by PFGE, used to determine the extent of overlap between adjacent fragments. The length of the contig from PAC-273-2 through PAC-H2-42 was approximately 900 kb and PAC-4, PAC-5 and c-165-24 were 70 kb, 180 kb and 340 kb proximal of PAC-273-2, respectively ( Figure 1a) . The distances D13S273 ± D13S272 and D13S272 ± D13S25 were calculated to be approximately 420 kb and 480 kb, respectively.
Deletion mapping at band 13q14 in B-CLL and MCL FISH was performed with probes for RB1 and D13S25 on 322 B-CLLs and 30 MCLs diagnosed according to established criteria (Cheson et al., 1996) . The results are detailed in Table 1 . The t(11;14)(q13;q32) was only present in MCLs as detected by our previously reported interphase cytogenetic probe set (DoÈ hner et al., 1997b) . The percentage of cells showing deletions ranged from 12 ± 98% with a mean of 68%.
Based on RB1 and D13S25 data we selected three groups of tumors for detailed deletion mapping (see Figure 3 ): (i) tumors with RB1 loss without D13S25 deletion (n=3; tumors 1 ± 3) to determine the distal border of the minimal deletion region; (ii) tumors with deletion of D13S25 without loss of RB1 (n=38; tumors 4 ± 41) to identify the proximal border of the minimal deletion; and (iii) tumors retaining both copies of RB1 and D13S25 (n=85; tumors 42 ± 126) to search for small deletions con®ned to this interval. (i) Tumor 1 had a large proximal deletion with a distal border at PAC-272-3 and a second telomeric deletion aecting PAC-58. The remaining single FISH signals of PAC-11 and PAC-58 showed a close spatial relation demonstrating that both deletions aected the same chromosome 13 homolog. Cohybridization of PAC-1 and PAC-55 revealed that a translocation breakpoint accompanied the deletion aecting PAC-58 ( Figure  2b ). In tumor 3, the deletion extended distally to PAC-10 while PAC-11 and PAC-272-3 showed a disperse hybridization pattern of one signal in interphase cells. Metaphase FISH revealed a disruption of the genomic region contained in PAC-272-3 (Figure 2c thereby de®ning the proximal border of the deletion segment within this 120 kb segment. (iii) 85 B-CLLs disomic for D13S25 and RB1 were analysed with probes PAC-10 (n=65), PAC-11 (n=62), PAC-272-3 (n=83), PAC-272-1-1 (n=80), PAC-3 (n=59), PAC-1 (n=73), PAC-48 (n=25), PAC-58 (n=85), PAC-55 (n=72) and PAC-52 (n=25). One of these 85 B-CLL (no. 42) showed a deletion (Figure 3) .
No evidence for frequent deletion of BRCA2
In addition to deletion mapping at 13q14 we tested 105 B-CLL tumors (40 tumors with deletions at 13q14 and 65 tumors without 13q14 deletions) with PACs p2G3 (n=48), p17M7 (n=86), p262M12 (n=79) and cosmid c874-15 (n=85) spanning a 600 kb region encompassing the BRCA2 gene at 13q12 (Schutte et al., 1995) . Only three tumors were found to show abnormalities. Tumor 3, in addition to the deletion at 13q14, showed a split signal with probe p17M7 on the metacentric marker chromosome. Tumor 23, in addition to the 13q14 deletion, showed a monoallelic deletion of all BRCA2 probes tested indicating a large deletion or monosomy 13. Only one of the 65 tumors disomic at 13q14 had a deletion of all BRCA2 probes in 36 ± 42% of cells indicating an isolated deletion at 13q12.
Identi®cation of transcripts from the minimally deleted regions
By exon ampli®cation 17 dierent candidate exons were identi®ed from the most frequently aected 13q14 subregions delineated by PAC-272-3 and PAC-58 (Figure 1b and c) . BLAST searches of the GenBank database with 6 exons derived from PAC-272-3 yielded matches to ESTs as detailed in Table 2 . For the PAC-58 derived exons no matching entries were found. Exon ampli®cation pools were used to isolate cDNAs from high density ®lters. Three cDNAs obtained for the PAC-272-3 region mapped to speci®c cosmids and Figure 3 Deletion mapping at chromosome band 13q14 in 39 B-CLL and 3 MCL (nos. 3, 40 and 41) tumors. From FISH analyses with probes for RB1 and D13S25 three groups of tumors were selected for detailed deletion mapping: Nos 1 ± 41 were selected for exclusive deletion of RB1 (nos 1 ± 3) or D13S25 (nos 4 ± 41). Tumor 42 was detected when screening 85 tumors retaining two copies of RB1 and D13S25 with 10 probes from the contig. Di=disomy, del=monoallelic deletion, bidel=biallelic deletion, p-del=partial deletion and p-bidel=partial biallelic deletion. The extent of monoallelic and biallelic deletions is indicated by light and dark gray colors, respectively. PAC-11 through PAC-58 from a contiguous probe set around D13S272. Sizes of probes and overlaps are not to scale contained individual exons derived from PAC-272-3, whereas no cDNA hybridizing speci®cally to the PAC-58 cosmids or containing exons derived from PAC-58 was found. Exon e53 was contained in opposite 5'-3' orientation in two otherwise unrelated cDNAs (Table  2) . Expression of the PAC-272-3 cDNAs was assessed by RT ± PCR from various tissues and from four B-CLL tumors with monoallelic deletions at 13q14 (Table  2) . Northern blot analyses of cDNAs ep272-3-t5 and ep272-3-t10, containing exon-53 in opposite direction, revealed dierent size transcripts (Figure 4) . The cDNA ep272-3 t4 detected a transcript of 2.4 kb size in poly(A) + RNA from spleen, thymus, testis, colon and leukocyte (data not shown).
Discussion
In the current study, we assembled a high resolution contig spanning the D13S273 ± D13S25 interval at band 13q14 frequently deleted in B-CLL. The D13S272 ± D13S25 distance previously determined to be less than 675 kb by Bullrich et al. (1996) was measured to be 480 kb and the D13S273 ± D13S25 distance was approximately 900 kb.
Detailed deletion mapping by FISH with probes from this contig allowed us to narrow down a commonly deleted segment of 400 kb (PAC-272-3, PAC-272-1-1, PAC-3, PAC-1, PAC-58 and PAC-48). This deletion region corresponds well to a deletion region most recently reported by Kalachikov et al. (1997) . In this study some tumors showed discontinuous deletions, similar to the results obtained by Bullrich et al. (1996) . We identi®ed such a discontinuous deletion only in one B-CLL (no. 1).
Within the 400 kb sized critical segment identi®ed in our study two subsegments appeared to be most important. In all tumors analysed the 13q14 aberrations extended to the 120 kb segment delineated by PAC-272-3. Although not the entire 120 kb fragment was lost in all tumors, a gene spanning part of this distance may be disrupted by aberrations aecting either end of it. A second segment delineated by PAC-58 was retained only in two tumors with 13q14 deletions in our study, possibly indicating another c272-3-2, -9 fetal brain, fetal liver, bone marrow, adrenal gland, thymus, testis, B-CLL a ± d a Exons identi®ed from PAC-272-3 and contained in cDNA fragments or database ESTs. b 272-3 t4, t5 and t10 were identi®ed from a fetal thymus cDNA library with the exon ampli®cation product derived from PAC-272-3 as probe. PCR 9-57 is a 130 bp RT ± PCR fragment obtained with primers designed from e9 and e57 sequences. Homologies to known ESTs were identi®ed by searching the Genbank EST database (dbEST) with cDNA fragments or exons via the NCBI server using the BLAST algorithm. (Altschul et al., 1990) . Editing and aligning of sequences were performed with the DNA-Star software package (DNASTAR, Madison, WI). High expression levels of a 1.5 kb transcript are found in spleen and small intestine whereas a weaker expression is detectable in other tissues critical region at the distal end of the 400 kb common deletion. This segment corresponds to the distal end of the critical region identi®ed by Kalachikov et al. (1997) , which was also aected in two tumors with discontinuous deletions.
A similar 13q14 deletion pattern as in B-CLL was observed in MCL. Consistent with this Liu et al. (1995) found deletions con®ned to marker D13S319 mapping to the RB1 ± D13S25 interval not only in B-CLL but also in one acute lymphoblastic leukemia and in two Bcell lymphomas. Of note is that the genomic region at D13S272 was aected in 21 of 30 (70%) MCL analysed in our study indicating a possible role of the putative new gene not only in the pathogenesis of B-CLL, but also in other tumors of lymphoid origin such as MCL.
An independent proximal deletion region at band 13q12 aecting BRCA2 was recently reported in 80% of B-CLL tumors by Garcia-Marco et al. (1996) . In contrast, we found abnormalities only in three of 105 tumors when testing with probes located at and 600 kb around BRCA2. Our results are compatible with a report in which no evidence for BRCA2 loss was found in 24 B-CLLs by Southern blot analysis (Panayiotidis et al., 1997) .
From the 13q14 segments contained in PAC-58 and PAC-272-3 we identi®ed expressed sequences by exon ampli®cation and cDNA library screening. In the PAC-272-3 region several exons were identi®ed which match to known ESTs and are contained in isolated cDNAs. Two of the identi®ed transcribed sequences correspond to ESTs recently reported by Kalachikov et al. (1997) . We identi®ed two additional cDNAs mapping to the smallest commonly aected segment delineated by PAC-272-3 in our study which were transcribed in a variety of tissues. Interestingly two of the transcripts from the minimal deletion region contained the same exon in opposite orientation within otherwise unrelated sequences. Since the identi®ed cDNAs are contained in the smallest commonly deleted 13q14 region thay can now be tested as B-CLL and MCL candidate tumor suppressor genes.
